Predictive and prognostic analysis of KRAS and MSI markers in treatment of urban African American colorectal cancer patients

被引:0
|
作者
Gopie, Priya [1 ]
Yazdy, Maryam [1 ]
Giwa, Bashira [1 ]
Solomon, Sanjeev [1 ]
Onojobi, Gladys [1 ]
Nouraie, Seyed-Mehdi [1 ]
Davis, Bonnie [1 ]
Sartip, Kamyar [1 ]
Babak, Shokrani [1 ]
Edward, Lee [1 ]
Brim, Hassan [1 ]
Ashktorab, Hassan [1 ]
机构
[1] Howard Univ Hosp, Washington, DC USA
关键词
D O I
10.1158/1538-7445.AM2014-3853
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3853
引用
收藏
页数:1
相关论文
共 50 条
  • [41] A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer
    Turkistani, Safaa
    Sugita, Bruna M.
    Fadda, Paolo
    Marchi, Rafael
    Afsari, Ali
    Naab, Tammey
    Apprey, Victor
    Copeland, Robert L., Jr.
    Campbell, Michael C.
    Cavalli, Luciane R.
    Kanaan, Yasmine
    BMC CANCER, 2021, 21 (01)
  • [42] A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer
    Safaa Turkistani
    Bruna M. Sugita
    Paolo Fadda
    Rafael Marchi
    Ali Afsari
    Tammey Naab
    Victor Apprey
    Robert L. Copeland
    Michael C. Campbell
    Luciane R. Cavalli
    Yasmine Kanaan
    BMC Cancer, 21
  • [43] SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients
    Kap, Elisabeth J.
    Seibold, Petra
    Scherer, Dominique
    Habermann, Nina
    Balavarca, Yesilda
    Jansen, Lina
    Zucknick, Manuela
    Becker, Natalia
    Hoffmeister, Michael
    Ulrich, Alexis
    Benner, Axel
    Ulrich, Cornelia M.
    Burwinkel, Barbara
    Brenner, Hermann
    Chang-Claude, Jenny
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (12) : 2993 - 3001
  • [44] Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer
    Sisic, Leila
    Vallboehmer, Daniel
    Stoecklein, Nikolas H.
    Blank, Susanne
    Schmidt, Thomas
    Driemel, Christiane
    Moehlendick, Birte
    Knoefel, Wolfram T.
    Odenthal, Margarete
    Ott, Katja
    ONCOLOGY LETTERS, 2015, 10 (02) : 869 - 874
  • [45] KRAS/BRAF MUTATIONS AND PTEN/P-AKT EXPRESSION AS PREDICTIVE MARKERS FOR CETUXIMAB IN JAPANESE COLORECTAL CANCER PATIENTS
    Yokota, Tomoya
    Shibata, Noriko
    Sakai, Yu
    Ura, Takashi
    Takahari, Daisuke
    Shitara, Kohei
    Shibata, Takeshi
    Muro, Kei
    Yatabe, Yasushi
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 34
  • [46] Meta-analysis of the predictive value of KRAS mutations in treatment response using cetuximab in colorectal cancer
    Tsoukalas, N.
    Tzovaras, A. A.
    Tolia, M.
    Kostakis, I. D.
    Papakostidi, A.
    Pistamaltzian, N.
    Ardavanis, A.
    JOURNAL OF BUON, 2012, 17 (01): : 73 - 78
  • [47] Prognostic role of systemic inflammatory markers in patients with metastatic MSI-h/dMMR colorectal cancer receiving immunotherapy.
    Bhamidipati, Deepak
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Kopetz, Scott
    Kee, Bryan K.
    Johnson, Benny
    Willis, Jason
    Dasari, Arvind
    Morelli, Maria Pia
    Parseghian, Christine Megerdichian
    Lee, Michael Sangmin
    Le, Phat
    Shen, John Paul Y. C.
    Ludford, Kaysia
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
    Zlobec, I.
    Molinari, F.
    Kovac, M.
    Bihl, M. P.
    Altermatt, H. J.
    Diebold, J.
    Frick, H.
    Germer, M.
    Horcic, M.
    Montani, M.
    Singer, G.
    Yurtsever, H.
    Zettl, A.
    Terracciano, L.
    Mazzucchelli, L.
    Saletti, P.
    Frattini, M.
    Heinimann, K.
    Lugli, A.
    BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 151 - 161
  • [49] Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer
    Stickeler, Elmar
    BREAST CARE, 2011, 6 (03) : 193 - 198
  • [50] Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
    I Zlobec
    F Molinari
    M Kovac
    M P Bihl
    H J Altermatt
    J Diebold
    H Frick
    M Germer
    M Horcic
    M Montani
    G Singer
    H Yurtsever
    A Zettl
    L Terracciano
    L Mazzucchelli
    P Saletti
    M Frattini
    K Heinimann
    A Lugli
    British Journal of Cancer, 2010, 102 : 151 - 161